News Releases Investor Relations Investor Menu Overview Events & Presentations Upcoming Events Past Events Presentations Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator News Releases SEC Filings Analyst Coverage Governance Documents & Charters Committee Composition IR Resources Investor FAQs Email Alerts Contact IR News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP September 4, 2018 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2018 Operating and Financial Results August 9, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018 July 26, 2018 View News Release > Summary ToggleNancy J. Wysenski Joins Dova Pharmaceuticals’ Board of Directors June 25, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Publication of Pivotal Phase 3 Data and Upcoming Congress Presentations for DOPTELET® (avatrombopag) June 4, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Availability of DOPTELET® in the United States May 31, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference May 29, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag) May 21, 2018 View News Release > Summary ToggleDova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results May 9, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018 May 2, 2018 View News Release > Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP September 4, 2018 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2018 Operating and Financial Results August 9, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018 July 26, 2018 View News Release > Summary ToggleNancy J. Wysenski Joins Dova Pharmaceuticals’ Board of Directors June 25, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Publication of Pivotal Phase 3 Data and Upcoming Congress Presentations for DOPTELET® (avatrombopag) June 4, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Availability of DOPTELET® in the United States May 31, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference May 29, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag) May 21, 2018 View News Release > Summary ToggleDova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results May 9, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018 May 2, 2018 View News Release > Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
